{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T15:35:03Z","timestamp":1768318503952,"version":"3.49.0"},"reference-count":54,"publisher":"American Public Health Association","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Public Health"],"published-print":{"date-parts":[[2013,8]]},"abstract":"<jats:p> Objectives. We estimated anogenital wart prevalence from 2003 to 2010 by gender and age group in a large US cohort with private insurance to detect potential decreases among people most likely to be affected by human papillomavirus (HPV) vaccination. <\/jats:p><jats:p> Methods. We restricted health care claims to those from individuals aged 10 to 39 years with continuous insurance within a given year. We derived anogenital wart diagnoses from a diagnosis of condyloma acuminata, or either a less specific viral wart diagnosis or genital wart medication combined with either a benign anogenital neoplasm or destruction or excision of a noncervical anogenital lesion. <\/jats:p><jats:p> Results. Prevalence increased slightly in 2003 to 2006, then significantly declined in 2007 to 2010 among girls aged 15 to 19 years; increased in 2003 to 2007, remained level through 2009, and declined in 2010 among women aged 20 to 24 years; and increased through 2009 but not in 2010 for women aged 25 to 39 years. For males aged 15 to 39 years, prevalence for each 5-year age group increased in 2003 to 2009, but no increases were observed for 2010. <\/jats:p><jats:p> Conclusions. These data indicate reductions in anogenital warts among US females aged 15 to 24 years, the age group most likely to be affected by introduction of the HPV vaccine. <\/jats:p>","DOI":"10.2105\/ajph.2012.301182","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T19:59:17Z","timestamp":1371153557000},"page":"1428-1435","source":"Crossref","is-referenced-by-count":82,"title":["Prevalence of Anogenital Warts Among Participants in Private Health Plans in the United States, 2003\u20132010: Potential Impact of Human Papillomavirus Vaccination"],"prefix":"10.2105","volume":"103","author":[{"given":"Elaine W.","family":"Flagg","sequence":"first","affiliation":[{"name":"At the time of the study, Elaine W. Flagg, Robert Schwartz, and Hillard Weinstock were with the Centers for Disease Control and Prevention, Atlanta, GA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Schwartz","sequence":"additional","affiliation":[{"name":"At the time of the study, Elaine W. Flagg, Robert Schwartz, and Hillard Weinstock were with the Centers for Disease Control and Prevention, Atlanta, GA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hillard","family":"Weinstock","sequence":"additional","affiliation":[{"name":"At the time of the study, Elaine W. Flagg, Robert Schwartz, and Hillard Weinstock were with the Centers for Disease Control and Prevention, Atlanta, GA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"844","reference":[{"key":"bib1","doi-asserted-by":"publisher","DOI":"10.1086\/597071"},{"key":"bib2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600688"},{"key":"bib3","doi-asserted-by":"publisher","DOI":"10.1086\/342109"},{"key":"bib4","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.2.560"},{"issue":"2","key":"bib5","first-page":"1","volume":"56","author":"Markowitz LE","year":"2007","journal-title":"MMWR Recomm Rep"},{"issue":"20","key":"bib6","first-page":"626","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"50","key":"bib7","first-page":"1705","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"20","key":"bib8","first-page":"630","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"34","key":"bib9","first-page":"671","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"bib10","doi-asserted-by":"publisher","DOI":"10.1071\/SH09137"},{"key":"bib11","doi-asserted-by":"publisher","DOI":"10.1071\/SH09145"},{"key":"bib12","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.02.019"},{"key":"bib13","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.7.4.437"},{"key":"bib14","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.10.018"},{"key":"bib15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c5128"},{"key":"bib16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061760"},{"key":"bib17","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir287"},{"key":"bib18","first-page":"463","volume-title":"Sexually Transmitted Diseases","author":"Egelkrout EM","year":"2008","edition":"4"},{"key":"bib19","doi-asserted-by":"publisher","DOI":"10.1086\/427557"},{"key":"bib20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.23.2995"},{"key":"bib21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04956-4"},{"key":"bib22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2004.12.008"},{"key":"bib23","volume-title":"International Classification of Disease, 9th Revision, Clinical Modification","year":"2011"},{"issue":"12","key":"bib24","first-page":"1","volume":"59","author":"Workowski KA","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"bib25","volume-title":"AHFS Drug Information","author":"Sinecatechins (topical)","year":"2012"},{"key":"bib26","volume-title":"AHFS Drug Information","author":"Imiquimod (topical)","year":"2012"},{"key":"bib27","volume-title":"AHFS Drug Information","author":"Podofilox (topical)","year":"2012"},{"key":"bib28","volume-title":"AHFS Drug Information","author":"Podophyllum resin (topical)","year":"2012"},{"key":"bib30","unstructured":"Healthcare Common Procedure Coding System (HCPCS). Baltimore, MD: Centers for Medicare and Medicaid Services; 2010."},{"key":"bib31","first-page":"72","volume-title":"Base SAS 9.3 Procedures Guide","author":"SAS Institute, Inc","year":"2011"},{"key":"bib32","doi-asserted-by":"publisher","DOI":"10.2307\/3001775"},{"key":"bib33","first-page":"5","volume-title":"SAS\/STAT 9.3 User\u2019s Guide","author":"SAS Institute Inc","year":"2011"},{"key":"bib34","doi-asserted-by":"publisher","DOI":"10.1007\/s10940-008-9048-4"},{"key":"bib35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2010.11.006"},{"key":"bib36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2008.11.010"},{"key":"bib37","unstructured":"Schiller JS, Euler GL. Vaccination coverage estimates from the National Health Interview Survey: United States, 2008. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Health Statistics; 2009."},{"key":"bib38","doi-asserted-by":"publisher","DOI":"10.1097\/00007435-200201000-00003"},{"key":"bib39","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e3181659236"},{"key":"bib40","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.89.6.825"},{"key":"bib41","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2011-3587"},{"key":"bib42","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2011-050109.157"},{"key":"bib43","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2011-050234"},{"key":"bib44","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2009.037788"},{"key":"bib45","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis405"},{"key":"bib46","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2011.300465"},{"key":"bib47","doi-asserted-by":"publisher","DOI":"10.1086\/375074"},{"key":"bib48","doi-asserted-by":"publisher","DOI":"10.1097\/01.olq.0000145851.76025.ad"},{"key":"bib49","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903136378"},{"key":"bib50","volume-title":"Sexually Transmitted Disease Surveillance, 2010","author":"Centers for Disease Control and Prevention","year":"2011"},{"issue":"36","key":"bib51","first-page":"997","volume":"58","author":"Centers for Disease Control and Prevention","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"32","key":"bib52","first-page":"1018","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"bib53","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)62029-8"},{"key":"bib54","doi-asserted-by":"publisher","DOI":"10.4161\/hv.7.2.13633"},{"issue":"40","key":"bib55","first-page":"1100","volume":"57","author":"Centers for Disease Control and Prevention","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["American Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ajph.aphapublications.org\/doi\/pdf\/10.2105\/AJPH.2012.301182","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T23:21:56Z","timestamp":1652138516000},"score":1,"resource":{"primary":{"URL":"https:\/\/ajph.aphapublications.org\/doi\/full\/10.2105\/AJPH.2012.301182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["10.2105\/AJPH.2012.301182"],"URL":"https:\/\/doi.org\/10.2105\/ajph.2012.301182","relation":{},"ISSN":["0090-0036","1541-0048"],"issn-type":[{"value":"0090-0036","type":"print"},{"value":"1541-0048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}